Aerpio Therapeutics
Cincinnati, US · Founded 2011 · Delaware corporation · 3 known investors
Find your way into Aerpio Therapeutics
182 people in our graph share verified history with the Aerpio Therapeutics team — schools, employers, funds. One of them is your warm intro.
Kenneth Morand, Ph.D.unlockedknows Joseph Gardner · together at P&G Pharmaceuticals (overlapped)
knows the team · via P&G Pharmaceuticals
×9knows the team · via Tulane University
knows the team · via Utah State University
Founders & leadership
Aerpio Therapeutics was founded in 2011 by Robert Shalwitz and Joseph Gardner.
RS
Robert ShalwitzCo-founder
JG
Joseph GardnerinFounderHe has prior experience in drug development, R&D, FDA affairs, and chemistry within the pharmaceuticals industry.
DN
Duane NashExecutive
KP
Kevin PetersExecutive
SP
Steve PakolaExecutive
IA
Ian A.W. HowesExecutive
Board
RA
Reinhard AmbrosBoard director
PW
Paul WeissBoard director
MS
Muneer SatterBoard director
CK
AD
Anupam DalalBoard director
JR
John RiceBoard director
Investors · 3
Reported raises · per SEC filings
Form D private placements$35M disclosed across 4 rounds · 2011–2016
▶$3.5MraisedNov 2016 · 53 investors · BiotechnologyRule 506(b)
▶$3.5MraisedNov 2016 · 53 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Joseph H. GardnerExecutive Officer, Director
- John RiceDirector
- Paul WeissDirector
- Campbell MurrayDirector
- Duane NashDirector
- Steve PakolaExecutive Officer
- Reinhard AmbrosDirector
- Anupam DalalDirector
- Chau KhuongDirector
- Adrienne GravesDirector
- Kevin PetersExecutive Officer
- Muneer SatterDirector
- Offering amount
- $4.6M
- Amount sold
- $3.5M
- First sale
- Oct 2016
- Incorporated
- Corporation, Delaware, 2011
- Federal exemptions
- 06b
▶$4.5MraisedApr 2016 · 54 investors · BiotechnologyRule 506(b)
▶$4.5MraisedApr 2016 · 54 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Reinhard AmbrosDirector
- Duane NashDirector
- Paul WeissDirector
- Muneer SatterDirector
- Adrienne GravesDirector
- Joseph H. GardnerExecutive Officer
- Kevin PetersExecutive Officer
- Chau KhuongDirector
- Steve PakolaExecutive Officer
- Anupam DalalDirector
- John RiceDirector
- Campbell MurrayDirector
- Offering amount
- $9.2M
- Amount sold
- $4.5M
- First sale
- Mar 2016
- Incorporated
- Corporation, Delaware, 2011
- Federal exemptions
- 06b
▶$22MraisedMay 2014 · 37 investors · BiotechnologyRule 506(b)
▶$22MraisedMay 2014 · 37 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Campbell MurrayDirector
- Kevin PetersExecutive Officer
- Joseph H. GardnerExecutive Officer, Director
- Paul WeissDirector
- Anupam DalalDirector
- Lauren SilvermanDirector
- Muneer SatterDirector
- Chau KhuongDirector
- Robert ShalwitzExecutive Officer
- Adrienne GravesDirector
- John RiceDirector
- Duane NashDirector
- Offering amount
- $22M
- Amount sold
- $22M
- First sale
- Apr 2014
- Incorporated
- Corporation, Delaware, 2011
- Federal exemptions
- 06b
▶$5MraisedJan 2012 · 24 investors · BiotechnologyRule 506(b)
▶$5MraisedJan 2012 · 24 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Robert ShalwitzExecutive Officer
- John RiceDirector
- Kevin PetersExecutive Officer
- Anupam DalalDirector
- Paul WeissDirector
- Ian A.W. HowesExecutive Officer
- Campbell MurrayDirector
- Joseph H. GardnerExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $5M
- First sale
- Dec 2011
- Incorporated
- Corporation, Delaware, 2011
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Aerpio Therapeutics went on to found or lead other companies.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2019 | $207.3K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2015 | $225K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- Who founded Aerpio Therapeutics?
- Aerpio Therapeutics was founded by Robert Shalwitz, Joseph Gardner in 2011.
- Who are Aerpio Therapeutics's investors?
- Aerpio Therapeutics's investors include CincyTech, Sofinnova Ventures, OrbiMed.
- How much funding has Aerpio Therapeutics raised?
- Aerpio Therapeutics has disclosed $35M raised across 4 rounds.
- Where is Aerpio Therapeutics headquartered?
- Aerpio Therapeutics is headquartered in Cincinnati, US.